News
Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...
Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...
15h
MedPage Today on MSNFDA Approves New Option for Chronic HivesThe FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...
The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.
Paris: Sanofi has received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment ...
A doctor may also prescribe over-the-counter (OTC) antihistamines or topical corticosteroids for more severe or painful reactions. People with immunological urticaria should note how their body ...
Traditionally, the lone star tick was the primary suspect in alpha-gal cases. However, recent studies reveal that other tick species, such as the western blacklegged and blacklegged ticks, may also ...
Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria . Approval based on phase 3 studies demonstrating Dupixent signifi ...
A shooting at Florida State University prompted reactions from lawmakers and renewed calls for gun control. Lawmakers ...
If a wasp does sting you, Texas Parks and Wildlife suggests the following: Remove the stinger. Washing sting with soap and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results